ST6Gal-I is known to be highly expressed in multiple types of cancer, including colorectal, ovarian, oral, breast, epithelial and liver carcinomas [6–11], and its expression has been positively correlated with adhesion, invasion and metastasis in tumor cells [12–14]. Here, ST6GAL1 is linked to neoplasm.